Last updated: 11/07/2018 16:03:02
A study to investigate the pharmacokinetics of oral naratriptan (GR85548A) in subjects with impaired hepatic function.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A study to investigate the pharmacokinetics of oral naratriptan (GR85548A) in subjects with impaired hepatic function.
Trial description: A study to investigate the pharmacokinetics of oral naratriptan (GR85548A) in subjects with impaired hepatic function.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: The pharmacokinetics of oral naratriptan in subjects with impaired hepatic function. Fuseau, E MD, Kempsford, RD MD, and Moss, J MD 39th Annual Scientific Meeting of the American Association for the Study of Headache 6/22/1997 New York, New York
Abstract: The pharmacokinetics of oral naratriptan in subjects with impaired renal or hepatic function. E. Fuseau, R. D. Kempsford J. Moss P. Snell A. Crisp J. M. Noblel G. A. Fordl 16th World Congress of Neurology 9/14/1997 Buenos Aires, Argentina
Abstract: The pharmacokinetics of oran naratriptan in subjects with impaired hepatic function. Fuseau, E, Kempsford, R D, and Moss, J 8th Congress of the International Headache Society 6/10/1997 Amsterdam, Netherlands
Fuseau E: The pharmacokinetics of oral naratriptan in subjects with impaired hepatic function CEPHALALGIA 1997;17(3):409
Medical condition
Migraine Disorders
Product
naratriptan
Collaborators
Not applicable
Study date(s)
November 1995 to Invalid Date
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website